Table 5.
Replication of Known Associations between Clinical Variables and Speckle-Tracking Parameters
| Clinical variable | Sex | Longitudinal strain | Early diastolic (e′) velocity* | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||||||
| Dalen, et al. | HyperGEN | Dalen, et al. | HyperGEN | ||||||||||
|
| |||||||||||||
| N | % Change/SD (95% CI)† | P | N | % Change/SD (95% CI) | P | N | % Change/SD (95% CI) | P | N | % Change/SD (95% CI) | P | ||
| Age | Women | 663 | −3.9 (−4.9, −2.9) | <0.001 | 1255 | −0.7 (−2.0, 0.5) | 0.23 | 663 | −22 (−24, −21) | <0.001 | 1255 | −18 (−20, −16) | <0.001 |
| Men | 603 | −3.1 (−4.3, −1.9) | <0.001 | 895 | −3.4 (−4.9, −1.8) | <0.001 | 603 | −21 (−22, −19) | <0.001 | 895 | −18 (−20, −16) | <0.001 | |
| Body-mass index | Women | 647 | −3.1 (−4.1, −2.1) | <0.001 | 1226 | −1.2 (−2.3, −0.1) | 0.029 | 647 | −4.4 (−5.8, −2.9) | <0.001 | 1226 | −0.8 (−2.4, 0.8) | 0.35 |
| Men | 594 | −3.9 (−5.1, −2.8) | <0.001 | 886 | −2.5 (−4.6, −0.5) | 0.018 | 594 | −6.7 (−8.4, −5.0) | <0.001 | 886 | −2.8 (−5.4, −0.2) | 0.033 | |
| Systolic blood pressure | Women | 610 | −3.0 (−4.1, −1.8) | <0.001 | 1222 | −2.7 (−3.8, −1.5) | <0.001 | 610 | −5.9 (−7.6, −4.3) | <0.001 | 1222 | −2.7 (−4.4, −1.0) | 0.002 |
| Men | 565 | −2.4 (−3.7, −1.1) | <0.001 | 884 | −1.7 (−3.3, 0.0) | 0.044 | 565 | −5.4 (−7.2, −3.5) | <0.001 | 884 | −4.4 (−6.4, −2.4) | <0.001 | |
| Diastolic blood pressure | Women | 610 | −2.5 (−3.6, −1.4) | <0.001 | 1222 | −3.6 (−4.8, −2.4) | <0.001 | 610 | −6.0 (−7.5, −4.4) | <0.001 | 1222 | −4.4 (−6.2, −2.7) | <0.001 |
| Men | 565 | −5.2 (−6.4, −4.0) | <0.001 | 884 | −1.4 (−2.9, 0.1) | 0.076 | 565 | −9.0 (−10.6, −7.3) | <0.001 | 884 | −4.7 (−6.6, −2.8) | <0.001 | |
| Non-HDL cholesterol | Women | 640 | −2.2 (−3.4, −1.0) | <0.001 | 1210 | −1.7 (−3.0, −0.5) | 0.005 | 640 | −2.1 (−3.9, −0.4) | 0.02 | 1210 | −2.6 (−4.3, −0.8) | 0.004 |
| Men | 591 | −2.3 (−3.6, −1.0) | <0.001 | 877 | −0.4 (−1.9, 1.1) | 0.58 | 591 | −4.4 (−6.3, −2.6) | <0.001 | 877 | −1.3 (−3.1, 0.6) | 0.18 | |
| HDL cholesterol | Women | 640 | 2.1 (1.0, 3.2) | <0.001 | 1210 | 1.7 (0.5, 2.9) | 0.006 | 640 | 1.5 (−0.1, 3.1) | 0.06 | 1210 | 2.1 (0.5, 3.8) | 0.012 |
| Men | 591 | 3.5 (2.2, 4.7) | <0.001 | 879 | 2.1 (0.2, 3.9) | 0.029 | 591 | 4.4 (2.6, 6.3) | <0.001 | 879 | 2.2 (−0.1, 4.4) | 0.063 | |
| Glomerular filtration rate | Women | 495 | −0.3 (−1.6, 1.1) | 0.67 | 1210 | 0.2 (−1.2, 1.6) | 0.79 | 495 | 0.5 (−1.4, 2.4) | 0.60 | 1210 | 2.1 (0.1, 4.2) | 0.04 |
| Men | 477 | 2.1 (0.6, 3.7) | 0.006 | 877 | 1.0 (−0.8, 2.8) | 0.27 | 477 | 3.5 (1.3, 5.7) | 0.002 | 877 | 1.0 (−1.3, 3.2) | 0.39 | |
| Glucose | Women | 640 | −0.9 (−2.0, 0.2) | 0.10 | 1210 | −2.9 (−4.3, −1.6) | <0.001 | 640 | −2.6 (−4.2, −1.0) | 0.001 | 1210 | −2.8 (−5.6, −0.1) | 0.046 |
| Men | 591 | −1.1 (−2.6, 0.4) | 0.16 | 877 | −1.7 (−3.6, −0.1) | 0.042 | 591 | −0.7 (−2.9, 1.5) | 0.51 | 877 | −2.9 (−5.0, −0.8) | 0.006 | |
The average of septal and lateral e′ tissue velocities was used as the dependent variable in the HyperGEN analyses.
Values represent percent change in left ventricular function parameter per standard deviation increase in clinical variable. All regression analyses for associations with clinical variables (except for age) were adjusted for age, as was done in the study by Dalen et al.
SD = standard deviation; CI = confidence interval; HDL = high-density lipoprotein